Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Roche Holding AG | 158 |
| 2 | 10X Genomics Inc | 155 |
| 3 | LG Chem Ltd | 90 |
| 4 | Covestro AG | 75 |
| 5 | Kimberly Clark Corp | 72 |
| 6 | GSK PLC | 59 |
| 7 | Weizmann Institute of Science | 59 |
| 8 | Labrador Diagnostics LLC | 48 |
| 9 | Massachusetts Institute of Technology | 47 |
| 10 | Arkray Inc | 46 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 2,929 |
| 2 | A61P | Therapeutic activity (drug indications) | 2,738 |
| 3 | G01N | Investigating / analysing materials | 1,813 |
| 4 | C12N | Microorganisms, enzymes | 1,081 |
| 5 | C07K | Peptides | 1,056 |
| 6 | C12Q | Measuring/testing involving enzymes | 873 |
| 7 | C07D | Heterocyclic compounds | 614 |
| 8 | Y02A | Climate change adaptation | 612 |
| 9 | A61L | Sterilising / disinfecting materials | 462 |
| 10 | Y10S | Cross-reference (legacy) | 252 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| GRAPHIC DIAGNOSIS PROBE FOR DISEASE ACCEPTING ACCUMULATING AMYLOID BY AZURE A ANALOG COMPOUND AND COMPOSITION FOR GRAPHIC DIAGNOSIS CONTAINING THE SAME | 2000 | 14 | |
| A kind of method of quick carry out Rui Shi Giemsa stainings | 2018 | 8 | |
| Method for purifying electronic mediator azure C | 2022 | 1 | |
| Method for detecting quality of Rui-Giemsa staining solution and method for improving quality of Rui-Giemsa staining solution | 2023 | 0 | |
| Method for purifying electronic mediator azure C | 2022 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Victor C. Yang | University of Michigan | 4 |
| 2 | Guangwen Cao | Nanjing University | 4 |
| 3 | Qingcai Jiao | 4 | |
| 4 | Tania García‐Mendiola | Universidad Autónoma de Madrid | 3 |
| 5 | Dutt Mk | 3 |
| 6 | F. Pariente | Universidad Autónoma de Madrid | 3 |
| 7 | Encarnación Lorenzo | Universidad Autónoma de Madrid | 3 |
| 8 | Gopinatha Suresh Kumar | Indian Institute of Chemical Biology | 3 |
| 9 | Robert A. Drongowski | University of Michigan | 3 |
| 10 | Liyan Kong | Hunan Normal University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin | 2007 | 155 | RNA Interference and Gene Delivery |
| Photocatalytic degradation of Azure and Sudan dyes using nano TiO2 | 2007 | 138 | TiO2 Photocatalysis and Solar Cells |
| A Metachromatic Dye-Atpase Method for The Simultaneous Identification of Skeletal Muscle Fiber Types I, IIA, IIB and IIC | 1990 | 116 | Mitochondrial Function and Pathology |
| Melanin synthesis by Sclerotinia sclerotiorum | 2009 | 93 | Phytochemicals and Antioxidant Activities |
| Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion | 2014 | 87 | Nanoplatforms for cancer theranostics |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Azure A?
Which organizations hold the most patents involving Azure A?
How has patent activity for Azure A changed in recent years?
What are the major CPC patent classifications associated with Azure A?
Which researchers have published the most papers on Azure A?